Cambridge Healthtech Institute’s Extracellular Biomarkers Summit, the newest addition to their biomarker and diagnostics portfolio will be held March 16-18, 2015 in Cambridge, MA.
The four-track event merges the well-established microRNA as Biomarkers and Diagnostics Conference with focused discussions on other leading areas of research: The event will focus on the role of circulating microRNA, exosomes and microvesicles, long non-coding RNA and extracellular RNA in cancer and other diseases, as well as their potential to serve as biomarkers in drug and diagnostic development. Coverage will include the isolation and characterization of exosomes and exRNA, including expression profiling and sequencing of exRNA; understanding the role of miRNA, lncRNA, and exosomes in disease mechanism, tumor metastasis, and intracellular communication; their potential as biomarkers in drug development, drug toxicity assessment, and patient stratification; and finally, their role as circulating biomarkers for disease diagnosis and prognosis.
Please join us to gain comprehensive coverage of extracellular biomarkers and hear from industry leaders on cutting-edge research, technologies and applications.
Find out more at – http://www.extracellularbiomarkers.com